Safety and Efficacy of Baloxavir Marboxil in Influenza-infected Children 5-11 Years of Age: A Post Hoc Analysis of a Phase 3 Study.

Background: miniSTONE-2 (NCT03629184) was a global, phase 3, randomized, controlled study that investigated the safety and efficacy of single-dose baloxavir marboxil in otherwise healthy children 1-<12 years of age and showed a positive risk-benefit profile. This post hoc analysis evaluated the safety and efficacy of baloxavir versus oseltamivir in children 5-11 years old with influenza.

Methods: Children received single-dose baloxavir or twice-daily oseltamivir for 5 days.

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.

BERENICE (NCT02132949) assessed the cardiac safety of the neoadjuvant−adjuvant pertuzumab−trastuzumab-based therapy for high-risk, HER2-positive early breast cancer (EBC). We describe key secondary objectives at final analysis. Eligible patients received dose-dense doxorubicin and cyclophosphamide q2w × 4 ➝ paclitaxel qw × 12 (Cohort A) or 5-fluorouracil, epirubicin, cyclophosphamide q3w × 4 ➝ docetaxel q3w × 4 (B) as per physician’s choice.

Determination of Polylactide Microstructure by Homonuclear Decoupled H NMR Spectroscopy.

The ring-opening polymerization (ROP) of lactide (the dilactone of lactic acid) produces poly(lactide) commonly referred to as poly(lactic acid) (PLA). The monomer lactide, has two stereogenic centers and thus, three stereoisomers are possible, namely: D-(R,R), L-(S,S) and meso-lactide. The rac-lactide is an equimolar mixture of D- and L-enantiomers.